These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets. Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404 [TBL] [Abstract][Full Text] [Related]
10. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene. Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245 [TBL] [Abstract][Full Text] [Related]
11. Expression of CCL9/MIP-1gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells. Iotti G; Ferrari-Amorotti G; Rosafio C; Corradini F; Lidonnici MR; Ronchetti M; Bardini M; Zhang Y; Martinez R; Blasi F; Calabretta B Oncogene; 2007 May; 26(24):3482-91. PubMed ID: 17160016 [TBL] [Abstract][Full Text] [Related]
12. Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias. So AY; Sookram R; Chaudhuri AA; Minisandram A; Cheng D; Xie C; Lim EL; Flores YG; Jiang S; Kim JT; Keown C; Ramakrishnan P; Baltimore D Blood; 2014 Aug; 124(9):1502-12. PubMed ID: 25006123 [TBL] [Abstract][Full Text] [Related]
13. The deregulated expression of miR-125b in acute myeloid leukemia is dependent on the transcription factor C/EBPα. Vargas Romero P; Cialfi S; Palermo R; De Blasio C; Checquolo S; Bellavia D; Chiaretti S; Foà R; Amadori A; Gulino A; Zardo G; Talora C; Screpanti I Leukemia; 2015 Dec; 29(12):2442-5. PubMed ID: 25982911 [No Abstract] [Full Text] [Related]
15. Overexpression of microRNA-125b inhibits human acute myeloid leukemia cells invasion, proliferation and promotes cells apoptosis by targeting NF-κB signaling pathway. Wang Y; Tang P; Chen Y; Chen J; Ma R; Sun L Biochem Biophys Res Commun; 2017 Jun; 488(1):60-66. PubMed ID: 28478034 [TBL] [Abstract][Full Text] [Related]
16. Reintroduction of C/EBPalpha in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis. Schepers H; Wierenga AT; van Gosliga D; Eggen BJ; Vellenga E; Schuringa JJ Blood; 2007 Aug; 110(4):1317-25. PubMed ID: 17475913 [TBL] [Abstract][Full Text] [Related]
17. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50. Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192 [TBL] [Abstract][Full Text] [Related]
18. C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia. Hughes JM; Legnini I; Salvatori B; Masciarelli S; Marchioni M; Fazi F; Morlando M; Bozzoni I; Fatica A Oncotarget; 2015 Jul; 6(21):18534-44. PubMed ID: 26053097 [TBL] [Abstract][Full Text] [Related]